Deal Watch: Medivation Enters Confidential Talks With Suitors, Including Sanofi

Bristol acquires Swedish biotech Cormorant to bolster its immuno-oncology franchise. Moderna quickly follows up its cancer partnership with another with Vertex to use mRNA approaches to treat cystic fibrosis.

The Pink Sheet regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between July 2-7. Deal Watch is supported by deal intelligence from Strategic Transactions.

As much as any completed deal, Sanofi's ongoing pursuit of Medivation Inc. has captured the attention of biopharma...

More from Archive

More from Pink Sheet